期刊文献+

2128例糖尿病患者临床特征及分型调查分析 被引量:3

Clinical characteristics and classification of 2 128 outpatients with diabetes
暂未订购
导出
摘要 目的 :分析门诊的糖尿病患者的临床特点及分型情况 ,以期对门诊糖尿病的就诊、教育及随访等提供依据。方法 :对近 1年来 2 1 2 8例门诊糖尿病患者进行资料登记 ,统计其各项临床资料 ,进行临床特征的分析。根据谷氨酸脱羧酶 (GAD)抗体初步分型 ,并分析GAD抗体与年龄、性别、病程等的关系。结果 :新发糖尿病患者 91 8例(4 3.1 4 % ) ;4 0岁以上的患者 1 883例 (88.6 % )。门诊GAD抗体检测 782例 (36 .7% ) ,阳性率为 4 .2 %。临床 1型糖尿病 1 2例 ,阳性率 33.3% ;2型 76 4例 ,阳性率 3.8%。男女不同性别GAD抗体阳性率分别为 5 .1 %和 3.2 % (P >0 .0 5 )。 1 ,5 ,1 0及 1 0年以上不同病程糖尿病患者GAD抗体阳性率分别为 4 .4 % ,4 .8% ,1 .7%和 4 .9% (P >0 .0 5 )。结论 :新发糖尿病常见于 4 0岁以上中老年患者。糖尿病分型仍以 2型为主。GAD抗体阳性率与性别。 Objective To determine the clinical characteristics of diabetic outpatients and their classification,and to provide some suggestions for diagnostics, education and follow up of outpatients.Methods We analyzed the data of 2 128 outpatients recorded in the past year, and studied the clinical characteristics, distribution of types and relation between glutamate decarboxylase antibody(GADA)and age, sex and duration. Results Of all the patients,918(43.1%)were new onset, and 1 883(88.6%) aged 40 or older.Altogether 782(36.7%)of the patients were done with GADA examination and 4.2% of them were GADA positive.Twelve patients were type 1 diabetes and 764 were type 2 diabetes, respectively with 33.3% and 3.8% GADA positive.The prevalence of GADA positive was 5.1% for men and 3.2% for women( P >0.05). The frequencies of GADA positive in patients with different duration (1 year, 5 years, 10 years and more) were 4.4%, 4.8%, 1.7% and 4.9%( P >0.05)respectively.Conclusion The new onset population of the studied patients is dominated by 40 year olds or older. Type 2 diabetes is the main type in the diabetes spectrum. The frequency of GADA positive is irrelevant to sex and duration.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2004年第2期184-186,共3页 Journal of Central South University :Medical Science
基金 国家"十五"科技攻关项目 (2 0 0 1BA70 2B0 4 )
关键词 糖尿病 谷氨酸脱羧酶抗体 临床特点 健康教育 血清学检测 diabetes glutamate decarboxylase antibody outpatient
  • 相关文献

参考文献10

  • 1Tuomi T,Lssen A,Li H,et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies[J]. Diabetes,1999,48(1):150-157.
  • 2Turner R,Stratton I,Manley S,et al .UKPDS 25 Autoantibodies to islet cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes[J]. Lancet, 1997,350(9087):1288-1293.
  • 3Decochez K,Tits J,Coolens JL,et al. High frenquency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age[J]. Diabetes Care,2000,23(6):838-844.
  • 4Lohmann T, Kellner K, Verlohren HJ, et al. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)[J]. Diabetologia, 2001, 44(8):1005-1010.
  • 5Landin M. Latent autoimmune diabetes in adults[J]. Ann NY Acad Sci, 2002, 958(1):112-116.
  • 6Pietropaolo M,Barinas-Mitchell E,Pietropaolo SL,et al. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes[J]. Diabetes, 2000, 49(1):32-38.
  • 7向红丁,吴纬,刘灿群,李康,冯晋光,张英廷,王凤歧,阎胜利,王春俭,徐跃初,徐端衍,傅祖植,刘尊永,李天麟,白锦,富振英,王克安.1996年全国糖尿病流行病学特点基线调查报告[J].中国糖尿病杂志,1998,6(3):131-133. 被引量:395
  • 8宋光华,孙崴,张萍,王玉琨,王颖,高政南,闻红,高晓虹,张翠莉,程艳.大连地区中老年人2型糖尿病的流行病学研究[J].中国糖尿病杂志,2002,10(2):112-113. 被引量:30
  • 9李霞,周智广,黄干,彭健,颜湘,王建平,杨琳.罗格列酮与胰岛素合用对LADA患者胰岛β细胞功能保护作用的初步观察[J].中国糖尿病杂志,2003,11(4):242-246. 被引量:63
  • 10周智广,伍汉文.成人隐匿性自身免疫性糖尿病的诊断与治疗[J].中华内分泌代谢杂志,1998,14(1):1-2. 被引量:98

二级参考文献15

  • 1向红丁,冯晋光,颜纯,高红军,黄敬生,杨迎燕,商维霞.我国东北一个县自然人群糖尿病流行病学调查[J].中国糖尿病杂志,1995,3(2):85-88. 被引量:36
  • 2王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 3[1]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000,85:76-80.
  • 4[2]Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol, 2001, 169:453-459.
  • 5[4]Johansson BL, Brog K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med, 2000, 17:181-189.
  • 6[5]Di Mario U, Dotta F. Modulation of antigen expression in relation to intervention strategies in type 1 diabetes. Diabete Metab Rev, 1993.245-249.
  • 7[6]Kobayashi T, Nakanishi K, Murase T , et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes, 1996,45:622-626.
  • 8[7]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve β cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130.
  • 9[8]Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev,2002,18:114-117.
  • 10胡远峰.胰岛素依赖型糖尿病的早期防治[J].中华内分泌代谢杂志,1997,13(2):67-68. 被引量:10

共引文献566

同被引文献32

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部